HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H P Hartung Selected Research

pentapeptide QYNAD

8/2005The pentapeptide QYNAD does not inhibit neuronal network activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H P Hartung Research Topics

Disease

32Multiple Sclerosis
07/2022 - 05/2000
10Relapsing-Remitting Multiple Sclerosis
08/2016 - 09/2000
8Demyelinating Diseases (Demyelinating Disease)
09/2012 - 01/2000
5Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2014 - 02/2000
5Chronic Progressive Multiple Sclerosis
02/2006 - 06/2001
5Guillain-Barre Syndrome
08/2005 - 03/2001
5Inflammation (Inflammations)
02/2002 - 07/2000
3Autoimmune Diseases (Autoimmune Disease)
07/2022 - 05/2000
3Infections
10/2001 - 11/2000
3Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
09/2001 - 09/2000
3Experimental Autoimmune Neuritis
09/2001 - 10/2000
2Leukocytosis (Pleocytosis)
01/2012 - 06/2005
2Progressive Multifocal Leukoencephalopathy
10/2011 - 07/2007
2Nervous System Diseases (Neurological Disorders)
02/2007 - 09/2001
2Necrosis
02/2006 - 01/2000
2Neoplasms (Cancer)
10/2002 - 09/2002
2Disease Progression
04/2001 - 10/2000
1Bacterial Infections (Bacterial Infection)
05/2013
1Sepsis (Septicemia)
05/2013
1Retrograde Degeneration
10/2012
1Optic Neuritis (Retrobulbar Neuritis)
10/2012
1Carcinogenesis
09/2012
1Gliosis
09/2012
1Alzheimer Disease (Alzheimer's Disease)
09/2012
1Genetic Predisposition to Disease (Genetic Predisposition)
06/2012
1Transverse Myelitis (Necrotizing Myelitis)
01/2012
1Myelitis
01/2012
1Venous Insufficiency
06/2011
1Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis)
03/2011
1Viral Encephalitis
03/2011
1Injection Site Reaction
10/2009
1Crohn Disease (Crohn's Disease)
07/2007
1Cardiotoxicity
09/2002
1Leukemia
09/2002
1Encephalomyelitis (Myeloencephalitis)
02/2002
1Paraparesis
09/2001

Drug/Important Bio-Agent (IBA)

7CytokinesIBA
05/2013 - 07/2000
6AntibodiesIBA
06/2012 - 09/2000
5Interferon beta-1b (Betaseron)FDA Link
01/2014 - 04/2001
4Intravenous Immunoglobulins (IVIG)FDA Link
09/2009 - 02/2002
4Proteins (Proteins, Gene)FDA Link
06/2005 - 09/2000
3Interferon beta-1aFDA Link
06/2009 - 04/2004
3Matrix Metalloproteinases (MMPs)IBA
06/2009 - 07/2000
3Peptide Hydrolases (Proteases)FDA Link
06/2009 - 01/2000
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2002 - 06/2000
3Messenger RNA (mRNA)IBA
12/2002 - 09/2000
3AutoantigensIBA
09/2001 - 02/2000
2Interleukin-6 (Interleukin 6)IBA
05/2013 - 06/2001
2Peptides (Polypeptides)IBA
05/2013 - 04/2002
2Retinaldehyde (Retinal)IBA
10/2012 - 11/2011
2Myelin-Oligodendrocyte GlycoproteinIBA
09/2012 - 03/2011
2InterferonsIBA
06/2012 - 02/2002
2Pharmaceutical PreparationsIBA
06/2012 - 07/2007
2Natalizumab (Tysabri)FDA Link
10/2011 - 07/2007
2Glatiramer Acetate (Copaxone)FDA Link
10/2009 - 04/2002
2Interferon-betaIBA
06/2009 - 02/2002
2ChemokinesIBA
11/2006 - 10/2000
2Interferon-gamma (Interferon, gamma)IBA
02/2006 - 10/2000
2Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
05/2005 - 03/2001
2Interleukin-10 (Interleukin 10)IBA
02/2003 - 06/2001
2Mitoxantrone (Novantrone)FDA LinkGeneric
10/2002 - 09/2002
2Apolipoproteins E (ApoE)IBA
09/2001 - 07/2000
2ApolipoproteinsIBA
09/2001 - 07/2000
1Alemtuzumab (Campath)FDA Link
07/2022
1Dimethyl FumarateIBA
08/2016
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2014
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2014
1Angiotensin Receptor AntagonistsIBA
01/2014
1Bacterial DNAIBA
05/2013
1ZymosanIBA
05/2013
1Fingolimod Hydrochloride (FTY720)FDA Link
12/2012
1Cadherins (E-Cadherin)IBA
09/2012
1Cell Adhesion MoleculesIBA
09/2012
1Immunomodulating AgentsIBA
06/2012
1Anti-Bacterial Agents (Antibiotics)IBA
01/2012
1SteroidsIBA
01/2012
1Chemokine CXCL13IBA
01/2012
1Ferritins (Ferritin)IBA
06/2011
1Myelin Basic ProteinIBA
03/2011
1Interleukin-4 (Interleukin 4)IBA
02/2006
1Sodium Channels (Sodium Channel)IBA
08/2005
1pentapeptide QYNADIBA
08/2005
1Neutralizing AntibodiesIBA
07/2005
1Oligoclonal BandsIBA
06/2005
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2003
1Cytotoxins (Cytolysins)IBA
09/2002
1GangliosidesIBA
10/2001
1Leflunomide (Arava)FDA LinkGeneric
09/2001
1Myelin ProteinsIBA
09/2001
1Myelin P0 Protein (Myelin Protein Zero)IBA
09/2001
1AntigensIBA
09/2001
1Immunoglobulin G (IgG)IBA
09/2001

Therapy/Procedure

10Therapeutics
07/2021 - 07/2000
3Stem Cell Transplantation
07/2022 - 05/2000
2Transplantation
07/2022 - 05/2000
2Plasma Exchange
02/2007 - 03/2001
2Surgical Amputation (Amputations)
11/2000 - 01/2000
1Traction
07/2022
1Radiotherapy
09/2002
1Subcutaneous Injections
09/2001